Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!

被引：2
|
作者：
Natarajan, Sundaram [1 ]
机构：
[1] Aditya Jyot Eye Hosp Pvt Ltd, Bombay, Maharashtra, India
来源：
INDIAN JOURNAL OF OPHTHALMOLOGY | 2013年 / 61卷 / 09期
关键词：
INTRAVITREAL BEVACIZUMAB AVASTIN; VASCULAR-PERMEABILITY FACTOR; PHOTODYNAMIC THERAPY; INTRAOCULAR INFLAMMATION; RANIBIZUMAB LUCENTIS; PEGAPTANIB SODIUM; VEGF-TRAP; SAFETY; EFFICACY; NEOVASCULARIZATION;
D O I：
10.4103/0301-4738.119421
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：475 / 478
页数：4
相关论文
共 50 条
  • [31] Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial
    Bailey, Clare
    Scott, Lauren J.
    Rogers, Chris A.
    Reeves, Barnaby C.
    Hamill, Barbra
    Peto, Tunde
    Chakravarthy, Usha
    Harding, Simon P.
    OPHTHALMOLOGY, 2019, 126 (01) : 75 - 86
  • [32] Treat-and-extend regimens with anti-vascular endothelial growth factor agents in age-related macular degeneration
    Yu, Siqing
    Ruckert, Rene
    Munk, Marion R.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2019, 14 (06) : 287 - 307
  • [33] The Value of Prior Response to Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration A HARBOR Subanalysis
    Khurana, Rahul N.
    Chang, Louis K.
    Hill, Lauren F.
    Ghanekar, Avanti
    Stoilov, Ivaylo
    OPHTHALMOLOGY RETINA, 2020, 4 (01): : 13 - 18
  • [34] Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration
    Cho, Han Joo
    Kim, Kyoung Min
    Kim, Hyoung Seok
    Lee, Dong Won
    Kim, Chul Gu
    Kim, Jong Woo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 166 : 112 - 119
  • [35] Choroidal Thickness following Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    So, Charlotte
    Ravage, Zac
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [36] Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
    Li, Emily
    Donati, Simone
    Lindsley, Kristina B.
    Krzystotik, Magdalena G.
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):
  • [37] Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration
    Okada, Mali
    Wong, Tien Yin
    Mitchell, Paul
    Eldem, Bora
    Talks, S. James
    Aslam, Tariq
    Daien, Vincent
    Rodriguez, Francisco J.
    Gale, Richard
    Barratt, Jane
    Finger, Robert P.
    Loewenstein, Anat
    JAMA OPHTHALMOLOGY, 2021, 139 (07) : 769 - 776
  • [38] GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Xu, Luna
    Mrejen, Sarah
    Jung, Jesse J.
    Gallego-Pinazo, Roberto
    Thompson, Desmond
    Marsiglia, Marcela
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02): : 176 - 186
  • [39] Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
    Joel Hanhart
    Rony Wiener
    Hashem Totah
    Evgeny Gelman
    Yishay Weill
    Adi Abulafia
    David Zadok
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 1907 - 1914
  • [40] Combination Therapy for Neovascular Age-related Macular Degeneration Refractory to Anti-Vascular Endothelial Growth Factor Agents
    Tozer, Kevin
    Roller, A. Brock
    Chong, Lawrence P.
    Sadda, SriniVas
    Folk, James C.
    Mahajan, Vinit B.
    Russell, Stephen R.
    Boldt, H. Culver
    Sohn, Elliott H.
    OPHTHALMOLOGY, 2013, 120 (10) : 2029 - 2034
12345